View in EDS HTML Full Text PDF Full Text

Selective blood-brain barrier permeabilization of brain metastases by a type 1 receptor-selective tumor necrosis factor mutein.

Saved in:
Bibliographic Details
Title: Selective blood-brain barrier permeabilization of brain metastases by a type 1 receptor-selective tumor necrosis factor mutein.
Authors: Munoz Pinto MF; Medical Research Council Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK.; Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Coimbra, Portugal., Campbell SJ; Medical Research Council Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK., Simoglou Karali C; Medical Research Council Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK.; MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK., Johanssen VA; Medical Research Council Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK., Bristow C; Medical Research Council Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK., Cheng VWT; Medical Research Council Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK.; Leeds Institute of Medical Research, University of Leeds, Leeds, UK., Zarghami N; Medical Research Council Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK., Larkin JR; Medical Research Council Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK., Pannell M; Medical Research Council Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK.; OxSonics Ltd., The Magdalen Centre, Oxford Science Park, Oxford, UK., Hearn A; Abzena Ltd., Babraham Research Campus, Babraham, Cambridge, UK., Chui C; Abzena Ltd., Babraham Research Campus, Babraham, Cambridge, UK., Brinquis Nunez B; Abzena Ltd., Babraham Research Campus, Babraham, Cambridge, UK., Bokma E; Abzena Ltd., Babraham Research Campus, Babraham, Cambridge, UK., Holgate R; Abzena Ltd., Babraham Research Campus, Babraham, Cambridge, UK., Anthony DC; Department of Pharmacology, University of Oxford, Oxford, UK., Sibson NR; Medical Research Council Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK.
Source: Neuro-oncology [Neuro Oncol] 2022 Jan 05; Vol. 24 (1), pp. 52-63.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34297105
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Selective blood-brain barrier permeabilization of brain metastases by a type 1 receptor-selective tumor necrosis factor mutein.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Munoz+Pinto+MF%22">Munoz Pinto MF</searchLink>; Medical Research Council Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK.; Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Coimbra, Portugal.<br /><searchLink fieldCode="AU" term="%22Campbell+SJ%22">Campbell SJ</searchLink>; Medical Research Council Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Simoglou+Karali+C%22">Simoglou Karali C</searchLink>; Medical Research Council Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK.; MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Johanssen+VA%22">Johanssen VA</searchLink>; Medical Research Council Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Bristow+C%22">Bristow C</searchLink>; Medical Research Council Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Cheng+VWT%22">Cheng VWT</searchLink>; Medical Research Council Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK.; Leeds Institute of Medical Research, University of Leeds, Leeds, UK.<br /><searchLink fieldCode="AU" term="%22Zarghami+N%22">Zarghami N</searchLink>; Medical Research Council Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Larkin+JR%22">Larkin JR</searchLink>; Medical Research Council Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Pannell+M%22">Pannell M</searchLink>; Medical Research Council Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK.; OxSonics Ltd., The Magdalen Centre, Oxford Science Park, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Hearn+A%22">Hearn A</searchLink>; Abzena Ltd., Babraham Research Campus, Babraham, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Chui+C%22">Chui C</searchLink>; Abzena Ltd., Babraham Research Campus, Babraham, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Brinquis+Nunez+B%22">Brinquis Nunez B</searchLink>; Abzena Ltd., Babraham Research Campus, Babraham, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Bokma+E%22">Bokma E</searchLink>; Abzena Ltd., Babraham Research Campus, Babraham, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Holgate+R%22">Holgate R</searchLink>; Abzena Ltd., Babraham Research Campus, Babraham, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Anthony+DC%22">Anthony DC</searchLink>; Department of Pharmacology, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Sibson+NR%22">Sibson NR</searchLink>; Medical Research Council Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100887420%22">Neuro-oncology</searchLink> [Neuro Oncol] 2022 Jan 05; Vol. 24 (1), pp. 52-63.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100887420 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1523-5866 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215228517%22">15228517 </searchLink><i>NLM ISO Abbreviation: </i>Neuro Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34297105
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/neuonc/noab177
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 52
    Titles:
      – TitleFull: Selective blood-brain barrier permeabilization of brain metastases by a type 1 receptor-selective tumor necrosis factor mutein.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Munoz Pinto MF
      – PersonEntity:
          Name:
            NameFull: Campbell SJ
      – PersonEntity:
          Name:
            NameFull: Simoglou Karali C
      – PersonEntity:
          Name:
            NameFull: Johanssen VA
      – PersonEntity:
          Name:
            NameFull: Bristow C
      – PersonEntity:
          Name:
            NameFull: Cheng VWT
      – PersonEntity:
          Name:
            NameFull: Zarghami N
      – PersonEntity:
          Name:
            NameFull: Larkin JR
      – PersonEntity:
          Name:
            NameFull: Pannell M
      – PersonEntity:
          Name:
            NameFull: Hearn A
      – PersonEntity:
          Name:
            NameFull: Chui C
      – PersonEntity:
          Name:
            NameFull: Brinquis Nunez B
      – PersonEntity:
          Name:
            NameFull: Bokma E
      – PersonEntity:
          Name:
            NameFull: Holgate R
      – PersonEntity:
          Name:
            NameFull: Anthony DC
      – PersonEntity:
          Name:
            NameFull: Sibson NR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 05
              M: 01
              Text: 2022 Jan 05
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1523-5866
          Numbering:
            – Type: volume
              Value: 24
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Neuro-oncology
              Type: main
ResultId 1